Methylglyoxal is an antibacterial effector produced by macrophages during infection
Cell Host & Microbe · 2025-07 · 33 (7) · 1121-1132.e5
DOI: 10.1016/j.chom.2025.05.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2025-07. Verfasst von Andrea Anaya-Sanchez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Graduate Group, University of California, Berkeley, Berkeley, CA, USA. Hauptthemen laut MEDLINE: Pyruvaldehyde, Macrophages, Listeria monocytogenes, Anti-Bacterial Agents. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Infected macrophages transition into aerobic glycolysis, a metabolic program crucial for controlling bacterial infection. However, antimicrobial mechanisms supported by aerobic glycolysis are unclear. Methylglyoxal is a highly toxic aldehyde that modifies proteins and DNA and is produced as a side product of glycolysis. We show that despite this toxicity, infected macrophages generate high levels of methylglyoxal during aerobic glycolysis while downregulating the detoxification system, including glyoxalase 1 (GLO1). Dampening methylglyoxal generation in mice resulted in enhanced survival of Listeria monocytogenes and Mycobacterium tuberculosis, whereas mice lacking Glo1 have increased methylglyoxal levels and improved infection control. Furthermore, bacteria unable to detoxify methylglyoxal (ΔgloA) exhibit attenuated virulence but are partially rescued in mice that cannot enter glycolysis and generate methylglyoxal. This loss of bacterial GloA results in up to a 1,000-fold greater genomic mutation frequency during infection. Collectively, these results suggest that methylglyoxal is an antimicrobial innate effector that defends against bacterial pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology Graduate Group, University of California, Berkeley, Berkeley, CA, USA.
- Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
- Division of Infectious Disease and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
- Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA.
- Microbiology Graduate Group, University of California, Berkeley, Berkeley, CA, USA; Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley,…
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- U.S. Food and Drug Administration
- NIH NIAID
- University of California, Los Angeles
- Henry Wheeler Center for Emerging and Neglected Diseases
- National Institutes of Health
Zitieren
APA
Anaya-Sanchez, A., Berry, S. B., Espich, S., Zilinskas, A., Tran, P. M., Agudelo, C., Samani, H., Darwin, K. H., Portnoy, D. A., & Stanley, S. A. (2025). Methylglyoxal is an antibacterial effector produced by macrophages during infection. Cell Host & Microbe, 33(7), 1121-1132.e5. https://doi.org/10.1016/j.chom.2025.05.026
Vancouver
Anaya-Sanchez A, Berry SB, Espich S, Zilinskas A, Tran PM, Agudelo C, et al. Methylglyoxal is an antibacterial effector produced by macrophages during infection. Cell Host & Microbe. 2025;33(7):1121-1132.e5. doi:10.1016/j.chom.2025.05.026
BibTeX
@article{AnayaSanchez2025,
author = {Anaya-Sanchez, Andrea and Berry, Samuel B and Espich, Scott and Zilinskas, Alex and Tran, Phuong M and Agudelo, Carolina and Samani, Helia and Darwin, K Heran and Portnoy, Daniel A and Stanley, Sarah A},
title = {Methylglyoxal is an antibacterial effector produced by macrophages during infection},
journal = {Cell Host & Microbe},
year = {2025},
volume = {33},
number = {7},
pages = {1121--1132.e5},
doi = {10.1016/j.chom.2025.05.026}
}
EUVIMED